Clinical trial
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At…
NCT00354809 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00354809 |
|---|---|
| Title | Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia |
| Official title | A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders, Insomnia |
| Intervention type | Drug |
| Interventions | GW679769 |
| Enrollment | 68 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jul 20, 2006 |
| Last update posted | Apr 16, 2015 |
| Countries | France, Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: